Fasting hypertriglyceridemia is significantly associated with an increased risk of cardiovascular events (OR 1.37), cardiovascular death (OR 1.80), myocardial infarction (OR 1.31), and pancreatitis.
Meta-Analysis (n=927,218)
Is fasting hypertriglyceridemia associated with an increased risk of cardiovascular events and pancreatitis?
Fasting hypertriglyceridemia is significantly associated with an increased risk of cardiovascular death, myocardial infarction, cardiovascular events, and acute pancreatitis.
Odds Ratio: 1.37 (95% CI 1.23–1.53)
BACKGROUND: Hypertriglyceridemia may be associated with important complications. The aim of this study is to estimate the magnitude of association and quality of supporting evidence linking hypertriglyceridemia to cardiovascular events and pancreatitis. METHODS: We conducted a systematic review of multiple electronic bibliographic databases and subsequent meta-analysis using a random effects model. Studies eligible for this review followed patients longitudinally and evaluated quantitatively the association of fasting hypertriglyceridemia with the outcomes of interest. Reviewers working independently and in duplicate reviewed studies and extracted data. RESULTS: 35 studies provided data sufficient for meta-analysis. The quality of these observational studies was moderate to low with fair level of multivariable adjustments and adequate exposure and outcome ascertainment. Fasting hypertriglyceridemia was significantly associated with cardiovascular death (odds ratios (OR) 1.80; 95% confidence interval (CI) 1.31-2.49), cardiovascular events (OR, 1.37; 95% CI, 1.23-1.53), myocardial infarction (OR, 1.31; 95% CI, 1.15-1.49), and pancreatitis (OR, 3.96; 95% CI, 1.27-12.34, in one study only). The association with all-cause mortality was not statistically significant. CONCLUSIONS: The current evidence suggests that fasting hypertriglyceridemia is associated with increased risk of cardiovascular death, MI, cardiovascular events, and possibly acute pancreatitis.Précis: hypertriglyceridemia is associated with increased risk of cardiovascular death, MI, cardiovascular events, and possibly acute pancreatitis.
Murad et al. (2012) conducted a meta-analysis in Hypertriglyceridemia (n=927,218). Fasting hypertriglyceridemia vs. Normal or lower fasting triglyceride levels was evaluated on Cardiovascular events (OR 1.37, 95% CI 1.23-1.53). Fasting hypertriglyceridemia is significantly associated with an increased risk of cardiovascular events (OR 1.37), cardiovascular death (OR 1.80), myocardial infarction (OR 1.31), and pancreatitis.